Clinical Trial Update: S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 safety study evaluating Keppra (levetiracetam) as adjunctive therapy in epilepsy has completed. The update indicates the trial has reached completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 4 | Status: COMPLETED